MedPath
FDA Approval

Ketorolac Tromethamine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Asclemed USA, Inc.
DUNS: 059888437
Effective Date
October 12, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ketorolac(60 mg in 2 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ASCLEMED USA INC. DBA ENOVACHEM

Asclemed USA, Inc.

059888437

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ketorolac Tromethamine

Product Details

NDC Product Code
76420-184
Application Number
ANDA074802
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
October 12, 2022
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8.7 mg in 2 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
KetorolacActive
Code: 4EVE5946BQClass: ACTIBQuantity: 60 mg in 2 mL
© Copyright 2025. All Rights Reserved by MedPath